ResMed Inc (RMD)
Days of sales outstanding (DSO)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 5.59 | 5.81 | 6.09 | 6.23 | 5.92 | 5.92 | 5.68 | 5.95 | 6.33 | 7.09 | 6.68 | 5.94 | 5.32 | 5.99 | 6.14 | 6.55 | 6.23 | 5.21 | 5.27 | 5.47 | |
DSO | days | 65.28 | 62.80 | 59.95 | 58.57 | 61.68 | 61.63 | 64.25 | 61.39 | 57.66 | 51.47 | 54.64 | 61.44 | 68.66 | 60.93 | 59.42 | 55.71 | 58.59 | 70.04 | 69.22 | 66.77 |
June 30, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.59
= 65.28
The Days Sales Outstanding (DSO) for ResMed Inc has shown some fluctuations over the past several quarters. The trend indicates that the company takes an average of around 60 to 65 days to collect its accounts receivable.
It's worth noting that there was an increase in DSO in the most recent quarter, rising to 65.28 days compared to the previous quarter. This suggests that the company may be facing challenges in collecting payments from customers in a timely manner.
Looking further back, the data shows that DSO has generally been within the range of 50 to 70 days over the past two years. The lowest DSO observed was 51.47 days in the first quarter of 2022, while the highest was 70.04 days in the third quarter of 2020.
Overall, the analysis of ResMed Inc's DSO indicates that the company's collection efficiency has varied, and it may be important for the company to focus on managing its accounts receivable effectively to ensure timely cash flows.
Peer comparison
Jun 30, 2024